Public Alert No. 05/2026 – Alert on the Mop-up of Counterfeit Dermazin (1% Silver Sulphadiazine) Cream
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers and the public about the circulation of counterfeit Dermazin (1% Silver Sulphadiazine) Cream. NAFDAC received a complaint from the legitimate Marketing Authorization Holder, Taylek Drugs Company Limited, concerning the sale of this counterfeit product. The packaging of the falsified Dermazin […]
